Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: Results from the EPIC-EURGAST study

International Journal of Cancer

Volumn 135, Issue 9, 2014, Pages 2065-2076

  Espinosa Parrilla, Yolanda ^a,b   Muñoz, Xavier ^c,d   Bonet, Catalina ^c   Garcia, Nadia ^c   Venceslá, Adoraciõn ^c   Yiannakouris, Nikos ^e   Naccarati, Alessio ^f   Sieri, Sabina ^g   Panico, Salvatore ^h   Huerta, José M ^i,j   Barricarte, Aurelio ^j,k   Menéndez, Virginia ^l   Sánchez Cantalejo, Emilio ^j,m,n   Dorronsoro, Miren ^j,o   Brennan, Paul ^p   Duarte Salles, Talita ^p   Bueno De Mesquita, H B ^q,r,s   Weiderpass, Elisabete ^t,u,v,w   Lund, Eiliv ^t   Clavel Chapelon, Françoise ^x,y   Boutron Ruault, Marie Christine ^x,y   Racine, Antoine ^x,y   Numans, Mattijs E ^r   Tumino, Rosario ^z   Canzian, Federico ^aa   Campa, Daniele ^aa   Sund, Malin ^ab   Johansson, Mattias ^p,ab   Ohlsson, Bodil ^ac   Lindkvist, Björn ^ad   Overvad, Kim ^ae,af   Tjønneland, Anne ^ag   Palli, Domenico ^ah   Travis, Ruth C ^ai   Khaw, Kay Tee ^aj   Wareham, Nick ^ak   Boeing, Heiner ^al   Nesi, Gabriella ^am   Riboli, Elio ^s   Gonzalez, Carlos A ^c   Sala, Núria ^c   more..

^a CSIC   (Spain)

^b UNIVERSITY OF CHILE   (Chile)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^e HELLENIC HEALTH FOUNDATION   (Greece)

^f Human Genetics Foundation   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^j CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^k INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^l Public Health Directorate   (Spain)

^m ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

ⁿ Granada Health Research Institute ibs GRANADA   (Spain)

^o BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^p INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^q NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s IMPERIAL COLLEGE LONDON   (United Kingdom)

^t UNIVERSITY OF TROMSØ   (Norway)

^u Department of Community Medicine Faculty of Health Sciences Arctic University of Norway ^*  (Norway)

^v KAROLINSKA INSTITUTE   (Sweden)

^w FOLKHÄLSAN RESEARCH CENTER   (Finland)

^x CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^y IGR   (France)

^z Civile MP Arezzo Hospital   (Italy)

^aa GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ab UMEÅ UNIVERSITY   (Sweden)

^ac LUND UNIVERSITY HOSPITAL   (Sweden)

^ad UNIVERSITY OF GOTHENBURG   (Sweden)

^ae AARHUS UNIVERSITY   (Denmark)

^af AARHUS UNIVERSITY   (Denmark)

^ag DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ah CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^ai UNIVERSITY OF OXFORD   (United Kingdom)

^aj UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ak UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^al GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^am UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

cancer genetic susceptibility; gastric adenocarcinoma; miRNA; miRNA cluster; polymorphisms; posttranscriptional regulation; prospective cohort; tagSNP

Indexed keywords

MICRORNA;

ADULT; ARTICLE; BCL2L11 GENE; CARCINOGENESIS; CDKN1A GENE; CDKN1C GENE; CHROMOSOME 7; CONTROLLED STUDY; DNMT3A GENE; DNMT3B GENE; E2F1 GENE; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MCL1 GENE; METHYLATION; MIDDLE AGED; MIR106 GENE; MIR25 GENE; MIR29 GENE; MIR93 GENE; MOLECULAR DYNAMICS; MYCN GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; PIK3R1 GENE; PRIORITY JOURNAL; RNA ISOLATION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; VEGFA GENE; X CHROMOSOME;

CANCER GENETIC SUSCEPTIBILITY; GASTRIC ADENOCARCINOMA; MIRNA; MIRNA CLUSTER; POLYMORPHISMS; POSTTRANSCRIPTIONAL REGULATION; PROSPECTIVE COHORT; TAGSNP;

ADENOCARCINOMA; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, X; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84906270676     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28850     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr.
2. Crew KD, Neugut AI,. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-62.
3. Houghton J, Wang TC,. Helicobacter pilory and gastric cancer: a new paradigm for Inflammation-associated epithelial cancers. Gastroenterology 2005; 128: 1567-78.
4. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
5. Lao-Siriex P, Caldas C, Fitzgerald RC,. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 2010; 20: 1-8.
6. Loh M, Koh KX, Yeo BH, et al. Meta-analysis of genetic polymorphisms and gastric cancer risk: variability in associations according to race. Eur J Cancer 2009; 45: 2562-8.
7. Saeki N, Ono H, Sakamoto H, et al. Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci 2013; 104: 1-8.
8. Sala N, Muñoz M, Travier N, et al. Prostate stem cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-Eurgast study. Int J Cancer 2012; 130: 2417-27.
9. Song JH, Meltzer SJ,. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 2012; 143: 35-47.
10. Bartel DP,. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
11. Kim VN, Nam JW,. Genomics of microRNA. Trends Genet 2006; 22: 165-73.
12. Muiños-Gimeno M, Montfort M, Bayes M, et al. Design and evaluation of a panel of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet 2010; 18: 218-26.
13. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
14. Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
15. Kloosterman WP, Plasterk RH,. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-50.
16. Ryan BM, Robles AI, Harris CC,. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
17. Garzon R, Calin GA, Croce CM,. MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-79.
18. Kumar MS, Lu J, Mercer KL, et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-7.
19. Esquela-Kerscher A, Slack FJ,. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
20. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8.
21. Katada T, Ishiguro H, Kuwabara Y, et al. microRNA expresion profile in undifferentiated gastric cancer. Int J Oncol 2009; 34: 537-42.
22. Kim YK, Yu J, Han TS, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-81.
23. Ueda T, Volinia S, Okumura H, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010; 11: 136-46.
24. Yang Q, Jie Z, Ye S, et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 2014; 33: 193-202.
25. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5: 1113-24.
26. Carneiro F, Moutinho C, Pera G, et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol 2007; 42: 618-27.
27. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9.
28. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-5.
29. Dudbridge F, Koeleman BPC,. Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am J Hum Genet 2004; 75: 424-35.
30. González JR, Armengol LL, Solé X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007; 23: 644-5.
31. Li X, Zhang Y, Zhang H, et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011; 9: 824-33.
32. Lang N, Liu M, Tang QL, et al. Effects of microRNA29 family members on proliferation and invasion of gastric cancer cell lines. Chin J Cancer 2010; 29: 603-10.
33. Kan T, Sato F, Ito T, et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009; 136: 1689-700.
34. Petrocca F, Visone R, Onelli MR, et al. E2F1-regulated microRNAs impair TGFb dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-86.
35. Garzon R, Liu S, Fabbri M, et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009; 113: 6411-18.
36. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 2007; 104: 15805-10.
37. Park SY, Lee JH, Ha M, et al. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 2009; 16: 23-9.
38. Mott JL, Kobayashi S, Bronk SF, et al. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133-40.
39. Jia CY, Li HH, Zhu XC, et al. MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS One 2011; 6: e27008.
40. Wu Q, Yang Z, Wang F, et al. MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells. J Cell Sci 2013; 126: 4220-9.
41. Muiños-Gimeno M, Espinosa-Parrilla Y, Guidi M, et al. Human microRNAs miR-22, miR-138-2, miR-148a, and miR-488 are associated with panic disorder and regulate several anxiety candidate genes and related pathways. Biol Psychiatry 2011; 69: 526-33.
42. Wu M, Jolicoeur N, Li Z, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis 2008; 29: 1710-16.
43. Liu Y, Zhang Y, Wen J, et al. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 2012; 7: e32230.
44. Calin GA, Ferracin M, Cimmino A, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005; 353: 1793-801.
45. Cummins JM, He Y, Leary RJ, et al. The colorectal microRNAome. Proc Natl Acad Sci USA 2006; 103: 3687-92.
46. Guo W, Dong Z, Guo Y, et al. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma. Mol Biol Rep 2012; 39: 9453-62.
47. Tahara E,. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004; 157: 327-49.
48. Yamashita K, Sakuramoto S, Watanabe M,. Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today 2011; 41: 24-38.